Selected research
Industry Research
Hyperthermia Cancer Treatment Devices Industry Research Report 2026
Market perspective
The global Hyperthermia Cancer Treatment Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hyperthermia Cancer Treatment Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hyperthermia Cancer Treatment Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hyperthermia Cancer Treatment Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hyperthermia Cancer Treatment Devices include Pyrexar Medical, Oncotherm, Andromedic, Yamamoto Vinita, Med-Logix, Thermofield, Celsius42, Dongseo Medicare and ThermaSolutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hyperthermia Cancer Treatment Devices market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hyperthermia Cancer Treatment Devices Market by Company
Pyrexar Medical
Oncotherm
Andromedic
Yamamoto Vinita
Med-Logix
Thermofield
Celsius42
Dongseo Medicare
ThermaSolutions
Verthermia
Combat Medical
Hydrosun
RanD Biotech
Shenzhen ET Medical Technology
Jiangsu Nova Medical Equipment
Hyperthermia Cancer Treatment Devices Segment by Type
Superficial Hyperthermia
Deep Regional Hyperthermia
Hyperthermia Cancer Treatment Devices Segment by Application
Breast Cancer
Cervical Cancer
Soft Tissue Sarcoma
Melanoma
Others
Hyperthermia Cancer Treatment Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperthermia Cancer Treatment Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hyperthermia Cancer Treatment Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperthermia Cancer Treatment Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hyperthermia Cancer Treatment Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hyperthermia Cancer Treatment Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hyperthermia Cancer Treatment Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Superficial Hyperthermia
- Deep Regional Hyperthermia
Applications
- Breast Cancer
- Cervical Cancer
- Soft Tissue Sarcoma
- Melanoma
- Others
Companies covered
- Pyrexar Medical
- Oncotherm
- Andromedic
- Yamamoto Vinita
- Med-Logix
- Thermofield
- Celsius42
- Dongseo Medicare
- ThermaSolutions
- Verthermia
- Combat Medical
- Hydrosun
- RanD Biotech
- Shenzhen ET Medical Technology
- Jiangsu Nova Medical Equipment
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hyperthermia Cancer Treatment Devices Market Size (2021-2032)
- 2.2.2 Global Hyperthermia Cancer Treatment Devices Sales (2021-2032)
- 2.2.3 Global Hyperthermia Cancer Treatment Devices Market Average Price (2021-2032)
- 2.3 Hyperthermia Cancer Treatment Devices by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Superficial Hyperthermia
- 2.3.3 Deep Regional Hyperthermia
- 2.4 Hyperthermia Cancer Treatment Devices by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Breast Cancer
- 2.4.3 Cervical Cancer
- 2.4.4 Soft Tissue Sarcoma
- 2.4.5 Melanoma
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hyperthermia Cancer Treatment Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hyperthermia Cancer Treatment Devices Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Hyperthermia Cancer Treatment Devices Revenue of Manufacturers (2021-2026)
- 3.4 Global Hyperthermia Cancer Treatment Devices Average Price by Manufacturers (2021-2026)
- 3.5 Global Hyperthermia Cancer Treatment Devices Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hyperthermia Cancer Treatment Devices, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hyperthermia Cancer Treatment Devices, Product Type & Application
- 3.8 Global Manufacturers of Hyperthermia Cancer Treatment Devices, Established Date
- 3.9 Global Hyperthermia Cancer Treatment Devices Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pyrexar Medical
- 4.1.1 Pyrexar Medical Company Information
- 4.1.2 Pyrexar Medical Business Overview
- 4.1.3 Pyrexar Medical Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pyrexar Medical Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.1.5 Pyrexar Medical Recent Developments
- 4.2 Oncotherm
- 4.2.1 Oncotherm Company Information
- 4.2.2 Oncotherm Business Overview
- 4.2.3 Oncotherm Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Oncotherm Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.2.5 Oncotherm Recent Developments
- 4.3 Andromedic
- 4.3.1 Andromedic Company Information
- 4.3.2 Andromedic Business Overview
- 4.3.3 Andromedic Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Andromedic Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.3.5 Andromedic Recent Developments
- 4.4 Yamamoto Vinita
- 4.4.1 Yamamoto Vinita Company Information
- 4.4.2 Yamamoto Vinita Business Overview
- 4.4.3 Yamamoto Vinita Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Yamamoto Vinita Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.4.5 Yamamoto Vinita Recent Developments
- 4.5 Med-Logix
- 4.5.1 Med-Logix Company Information
- 4.5.2 Med-Logix Business Overview
- 4.5.3 Med-Logix Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Med-Logix Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.5.5 Med-Logix Recent Developments
- 4.6 Thermofield
- 4.6.1 Thermofield Company Information
- 4.6.2 Thermofield Business Overview
- 4.6.3 Thermofield Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Thermofield Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.6.5 Thermofield Recent Developments
- 4.7 Celsius42
- 4.7.1 Celsius42 Company Information
- 4.7.2 Celsius42 Business Overview
- 4.7.3 Celsius42 Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Celsius42 Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.7.5 Celsius42 Recent Developments
- 4.8 Dongseo Medicare
- 4.8.1 Dongseo Medicare Company Information
- 4.8.2 Dongseo Medicare Business Overview
- 4.8.3 Dongseo Medicare Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dongseo Medicare Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.8.5 Dongseo Medicare Recent Developments
- 4.9 ThermaSolutions
- 4.9.1 ThermaSolutions Company Information
- 4.9.2 ThermaSolutions Business Overview
- 4.9.3 ThermaSolutions Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ThermaSolutions Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.9.5 ThermaSolutions Recent Developments
- 4.10 Verthermia
- 4.10.1 Verthermia Company Information
- 4.10.2 Verthermia Business Overview
- 4.10.3 Verthermia Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Verthermia Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.10.5 Verthermia Recent Developments
- 4.11 Combat Medical
- 4.11.1 Combat Medical Company Information
- 4.11.2 Combat Medical Business Overview
- 4.11.3 Combat Medical Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Combat Medical Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.11.5 Combat Medical Recent Developments
- 4.12 Hydrosun
- 4.12.1 Hydrosun Company Information
- 4.12.2 Hydrosun Business Overview
- 4.12.3 Hydrosun Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hydrosun Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.12.5 Hydrosun Recent Developments
- 4.13 RanD Biotech
- 4.13.1 RanD Biotech Company Information
- 4.13.2 RanD Biotech Business Overview
- 4.13.3 RanD Biotech Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 RanD Biotech Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.13.5 RanD Biotech Recent Developments
- 4.14 Shenzhen ET Medical Technology
- 4.14.1 Shenzhen ET Medical Technology Company Information
- 4.14.2 Shenzhen ET Medical Technology Business Overview
- 4.14.3 Shenzhen ET Medical Technology Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Shenzhen ET Medical Technology Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.14.5 Shenzhen ET Medical Technology Recent Developments
- 4.15 Jiangsu Nova Medical Equipment
- 4.15.1 Jiangsu Nova Medical Equipment Company Information
- 4.15.2 Jiangsu Nova Medical Equipment Business Overview
- 4.15.3 Jiangsu Nova Medical Equipment Hyperthermia Cancer Treatment Devices Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Jiangsu Nova Medical Equipment Hyperthermia Cancer Treatment Devices Product Portfolio
- 4.15.5 Jiangsu Nova Medical Equipment Recent Developments
5 Global Hyperthermia Cancer Treatment Devices Market Scenario by Region
- 5.1 Global Hyperthermia Cancer Treatment Devices Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hyperthermia Cancer Treatment Devices Sales by Region: 2021-2032
- 5.2.1 Global Hyperthermia Cancer Treatment Devices Sales by Region: 2021-2026
- 5.2.2 Global Hyperthermia Cancer Treatment Devices Sales by Region: 2027-2032
- 5.3 Global Hyperthermia Cancer Treatment Devices Revenue by Region: 2021-2032
- 5.3.1 Global Hyperthermia Cancer Treatment Devices Revenue by Region: 2021-2026
- 5.3.2 Global Hyperthermia Cancer Treatment Devices Revenue by Region: 2027-2032
- 5.4 North America Hyperthermia Cancer Treatment Devices Market Facts & Figures by Country
- 5.4.1 North America Hyperthermia Cancer Treatment Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 5.4.3 North America Hyperthermia Cancer Treatment Devices Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hyperthermia Cancer Treatment Devices Market Facts & Figures by Country
- 5.5.1 Europe Hyperthermia Cancer Treatment Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 5.5.3 Europe Hyperthermia Cancer Treatment Devices Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hyperthermia Cancer Treatment Devices Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hyperthermia Cancer Treatment Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hyperthermia Cancer Treatment Devices Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hyperthermia Cancer Treatment Devices Market Facts & Figures by Country
- 5.7.1 South America Hyperthermia Cancer Treatment Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 5.7.3 South America Hyperthermia Cancer Treatment Devices Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hyperthermia Cancer Treatment Devices Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hyperthermia Cancer Treatment Devices Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hyperthermia Cancer Treatment Devices Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hyperthermia Cancer Treatment Devices Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hyperthermia Cancer Treatment Devices Sales by Type (2021-2032)
- 6.1.1 Global Hyperthermia Cancer Treatment Devices Sales by Type (2021-2032) & (units)
- 6.1.2 Global Hyperthermia Cancer Treatment Devices Sales Market Share by Type (2021-2032)
- 6.2 Global Hyperthermia Cancer Treatment Devices Revenue by Type (2021-2032)
- 6.2.1 Global Hyperthermia Cancer Treatment Devices Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hyperthermia Cancer Treatment Devices Revenue Market Share by Type (2021-2032)
- 6.3 Global Hyperthermia Cancer Treatment Devices Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hyperthermia Cancer Treatment Devices Sales by Application (2021-2032)
- 7.1.1 Global Hyperthermia Cancer Treatment Devices Sales by Application (2021-2032) & (units)
- 7.1.2 Global Hyperthermia Cancer Treatment Devices Sales Market Share by Application (2021-2032)
- 7.2 Global Hyperthermia Cancer Treatment Devices Revenue by Application (2021-2032)
- 7.2.1 Global Hyperthermia Cancer Treatment Devices Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hyperthermia Cancer Treatment Devices Revenue Market Share by Application (2021-2032)
- 7.3 Global Hyperthermia Cancer Treatment Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hyperthermia Cancer Treatment Devices Value Chain Analysis
- 8.1.1 Hyperthermia Cancer Treatment Devices Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hyperthermia Cancer Treatment Devices Production Mode & Process
- 8.2 Hyperthermia Cancer Treatment Devices Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hyperthermia Cancer Treatment Devices Distributors
- 8.2.3 Hyperthermia Cancer Treatment Devices Customers
9 Global Hyperthermia Cancer Treatment Devices Analyzing Market Dynamics
- 9.1 Hyperthermia Cancer Treatment Devices Industry Trends
- 9.2 Hyperthermia Cancer Treatment Devices Industry Drivers
- 9.3 Hyperthermia Cancer Treatment Devices Industry Opportunities and Challenges
- 9.4 Hyperthermia Cancer Treatment Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst